Project Search Results


Research Categorization


Project Details


Contact Researcher and Awardee Organization


Funding Organization

Displaying 1 - 9 of 9 Projects
Project # Contact PI Funding Organization Fiscal Year
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension
GC-2013910 Edison, Paul Alzheimer's Drug Discovery Foundation 2017
Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial
GH-2012563 HOLMES, CLIVE Alzheimer's Drug Discovery Foundation 2015
Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people
20140901-Hainsworth-2014 Hainsworth, Atticus Alzheimer's Drug Discovery Foundation 2014
Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects
222-Holscher-2014 Holscher, Christian Alzheimer's Drug Discovery Foundation 2014
Repurposed drugs targeting the unfolded protein response to prevent neurodegeneration in dementia
223-Mallucci-2014 Mallucci, Giovanna Alzheimer's Drug Discovery Foundation 2014
Effect of Novel GLP1 analogue, Liraglutide on microglial activation and cerebral glucose metabolism in mild Alzheimer's disease.
20111202-Edison-2011 Edison, Paul Alzheimer's Drug Discovery Foundation 2011
Music as a memory aid in Alzheimer's Disease
AADRF-Baird-2011 Baird, Amee Dementia Australia Research Foundation 2011
Characterization in vivo of a newly identified peptide of potential pivotal significance to Alzheimer's disease
290203-Greenfield-2009 Greenfield, Susan Alzheimer's Drug Discovery Foundation 2009